Author
J.E. Debreczeni
Also Known As
A. Pal, C.H. Arrowsmith, Debreczeni, J.E., Debreczeni, Judit Eva, J. Debreczeni, J. Debreczeni,, J. E. Debreczeni, J. É. Debreczeni, J.E. Debreczeni, Judit Debreczeni
158
Publications
5.5K
Citations
36
H-Index
59
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 17 | 18 | 1.2K |
2 | Natural Sciences | 16 | 17 | 1.1K |
3 | Biochemistry | 13 | 13 | 885 |
4 | Engineering | 1 | 1 | 13 |
5 | Allergy | 1 | 1 | 34 |
J.E. Debreczeni
×
48
Publications
4.4K
Citations
34
H-Index
| Year | Citations | |
|---|---|---|
2023 | 758 | |
2008 | 345 | |
Structure- and Reactivity-Based Development of Covalent Inhibitors of the Activating and Gatekeeper Mutant Forms of the Epidermal Growth Factor Receptor (EGFR) Richard A. Ward, Mark J. Anderton, Susan Ashton, Journal of Medicinal Chemistry Covalent InhibitorsDrug TargetThiol ReactivityTyrosine KinaseMolecular Biology | 2013 | 257 |
2006 | 232 | |
2005 | 197 | |
2006 | 166 | |
2017 | 156 | |
2005 | 149 | |
2007 | 132 | |
2009 | 115 |
Page 1
Page 1